Nasdaq

Is Dave & Buster's A Buy On The Pullback?

Shares of Dave & Buster's Entertainment (NASDAQ: PLAY) are trading about 9% lower after reporting fiscal second-quarter revenue that was below consensus expectations. The company's top line was down 85% year over year as a result of store...
Related topics: US Equity Markets

Read More →

This Key Metric Should Get Peloton Investors Excited

Few companies can credit the COVID-19 pandemic for boosting their businesses quite like Peloton (NASDAQ: PTON) can. Shares of the high-end fitness equipment maker have more than tripled since its IPO 12 months ago, catapulting the company to a $25.9...
Related topics: US Equity Markets, Initial Public Offering

Read More →

Roku Suddenly Looks Vulnerable In Peacock Dispute

Apparently, Roku (NASDAQ: ROKU) has ruffled a few feathers at Comcast's (NASDAQ: CMCSA) Peacock.After Roku blocked the NBCUniversal streaming service from its platform when it launched July, Comcast is now striking back against the leading...
Related topics: Comcast, Nbcuniversal

Read More →

Costco Earnings: 3 Things To Watch

Investors have some good reasons to look forward to the next earnings report from Costco Wholesale (NASDAQ: COST). The retailing giant's last few monthly sales reports have painted a bright picture for growth through August, and that's been...
Related topics: Costco Wholesale, US Equity Markets

Read More →

Why Compass Pathways Is Soaring Today

Last Friday, U.K.-based Compass Pathways (NASDAQ: CMPS) became the first psychedelic medicine company to go public on a major U.S. exchange. The drugmaker's shares promptly rose by an eye-catching 70.5% during their first day of trading on the...

Read More →

After Years Of Setbacks, Apple Launches Online Sales In India This Week

Apple (NASDAQ: AAPL) has been trying to expand its presence in India over the past decade, but faced numerous setbacks related to local regulations. Back in 2012, India's Department of Industrial Policy and Promotion relaxed rules around foreign...
Related topics: Apple (AAPL), India, US Equity Markets

Read More →

Stitch Fix: The Earnings Trends To Watch On Tuesday

This week could be a big one for Stitch Fix (NASDAQ: SFIX) investors. The apparel specialist's last earnings report included lots of potentially bad news for the business, including slumping profitability and weak user growth. But management said at...
Related topics: US Equity Markets

Read More →

If You Invested $5,000 In Moderna In January, This Is How Much You'd Have Now

Are you the kind of investor who's leery of buying stocks immediately following their initial public offerings (IPOs)? If so, you might like Moderna's (NASDAQ: MRNA) story.In December 2018, Moderna conducted the biggest biotech IPO ever. If you had...
Related topics: Initial Public Offering, US Equity Markets

Read More →

Market Turmoil: Buy This Crash-proof Stock Now

Since the start of the month, the S&P 500 and the Nasdaq have seen their ups and downs. But overall, we're looking at losses of 7.3% and 10.5%, respectively, since their recent highs on Sept. 2. The continuation of the coronavirus crisis and...
Related topics: US Equity Markets

Read More →

Does Cassava Sciences Have The Alzheimer's Disease Drug We've Been Waiting For?

Shares of Cassava Sciences (NASDAQ: SAVA) rocketed higher last week in response to compelling results from a clinical trial with sumifilam, an experimental treatment for Alzheimer's patients. This disease affects roughly one in 10 adults over 65,...
Related topics: Alzheimer's Disease, Clinical Trials

Read More →

Herman Miller Survives A Stress Test

Shares of iconic furniture designer and manufacturer Herman Miller (NASDAQ: MLHR) raced forward on Thursday of this past week, soaring more than 33% following the release of a resilient first-quarter fiscal 2021 quarterly report. Investors had...
Related topics: US Equity Markets

Read More →

Tech Stocks This Week: Snowflake Goes Public, Apple Falls, And More

A sell-off in tech continued this week, leaving the tech-heavy Nasdaq Composite down about 10% in September. The sell-off follows significant year-to-date outperformance for tech stocks. Even including the recent drawdown in the Nasdaq, the index is...
Related topics: Apple (AAPL), US Equity Markets

Read More →

Comcast Doesn't Care If You Want To Cut The Cord

With the growing number of cord-cutters and cord-nevers, Comcast (NASDAQ: CMCSA) has had to change its video strategy over the years. And while the cable TV business used to be the centerpiece of its operations, that's drastically shifted to its...
Related topics: Comcast, Tech Videos

Read More →

Microsoft And Sony Are Racing To Offer Gamers More Exclusive Titles

The upcoming console battle between the Microsoft (NASDAQ: MSFT) Xbox Series X and Sony (NYSE: SNE) PlayStation 5 is just around the corner with both systems slated to launch this holiday season. However, unlike previous console cycles, this new...
Related topics: Microsoft, Sony, Xbox, Playstation

Read More →

3 Ways Peloton Is Expanding The Appeal Of Its Product

Peloton Interactive (NASDAQ: PTON) is making great progress in capturing its addressable market. Connected fitness subscribers more than doubled to 1.09 million last quarter. Peloton has estimated its serviceable addressable market to be 14...
Related topics: US Equity Markets

Read More →

There Are 130 Video Apps That Get Apple's Reduced Cut

Apple (NASDAQ: AAPL) has been under intense antitrust scrutiny regarding the App Store, with CEO Tim Cook testifying virtually in front of Congress over the summer. One particularly contentious issue has been a deal that the Mac maker cut with...
Related topics: Tech Videos, Apple's App Store, Apple, Amazon

Read More →

Better Coronavirus Stock: Astrazeneca Or Moderna?

Only three coronavirus vaccine candidates with the potential to be marketed in the U.S. are currently in late-stage testing. AstraZeneca (NYSE: AZN) and Moderna (NASDAQ: MRNA) claim two of the three.If you think that these two stocks are beating the...
Related topics: Astrazeneca, US Equity Markets

Read More →

Is This Market Correction The Right Time To Buy Fluidigm?

With shrinking revenues, unprofitable operations, and only $45.4 million in cash against trailing-12-month operating expenses of $115.4 million, cell analysis hardware company Fluidigm (NASDAQ: FLDM) might not seem like an obvious candidate for...
Related topics: US Equity Markets

Read More →

Where Will Amgen Be In 1 Year?

Biotech superstar Amgen (NASDAQ: AMGN) finds itself in an incredibly exciting position in 2020, with a lot to look forward to in 2021. The company has a number of late-stage clinical trials due to report results next year and is engaged in the...
Related topics: Amgen, US Equity Markets

Read More →

Are The Gains Over For This Early Leader In The Coronavirus Vaccine Race?

Although Inovio's (NASDAQ: INO) shares lost half of their value in a little over a month this summer, shareholders have since given the biotech company a glimmer of hope. The stock soared 20% in one trading session this week on optimism that details...
Related topics: US Equity Markets

Read More →
What is noozilla?
Noozilla is an independent news aggregation service with a categorization engine that categorizes millions of news stories by subject.